Potential Use of Agave Genus in Neuroinflammation Management
Authors:
- Maribel Herrera-RuizMHMaribel Herrera-Ruiz
- Enrique Jiménez-FerrerEJEnrique Jiménez-Ferrer
- Manasés González-CortazarManasés González-Cortazar
- Alejandro ZamilpaAlejandro Zamilpa
- Alexandre Cardoso-TaketaACAlexandre Cardoso-Taketa
- Martha Lucía Arenas-OcampoMAMartha Lucía Arenas-Ocampo
- Antonio Ruperto Jiménez-AparicioAJAntonio Ruperto Jiménez-Aparicio
- Nayeli Monterrosas-BrissonNMNayeli Monterrosas-Brisson
Open Access
Abstract
Agavaceae contains about 480 species, commonly used in the production of alcoholic beverages such as tequila and mezcal, making it a resource of economic and cultural importance. Uses of this plant rely mainly on the stem; other components such as the leaves are discarded, generating agro-industrial waste, despite being a source of bioactive and nutraceutical products. Reports show anti-inflammatory and anti-neuroinflammatory effects of these species, with flavonoids and saponins being mainly responsible. Neuroinflammation is a brain process that plays a key role in the pathogenesis of various neurodegenerative disorders and its effects contribute greatly to mortality and morbidity worldwide. This can be triggered by mechanisms such as glial reactions that lead to the release of inflammatory and oxidative molecules, causing damage to the CNS. Treatments do not cure chronic disease associated with inflammation; they only slow its progression, producing side effects that affect quality of life. Plant-based therapy is promising for treating these diseases. Pharmacological activities have been described for the Agavaceae family; however, their role in neuroinflammation has not been fully investigated, and represents an important target for study. This review synthesizes the existing literature on the biologically active compounds of Agave species that are related in some way to inflammation, which will allow us to propose a line of research with this genus on the forefront to orient experimental designs for treating neuroinflammation and associated diseases.Keywords
Funding Information
- Health Research Fund (FIS/IMSS) (FIS/IMSS/PROT/G8/1820)
This publication has 121 references indexed in Scilit:
- LPS induces mediators of neuroinflammation, cell proliferation, and GFAP expression in human astrocytoma cells U373MG: the anti-inflammatory and anti-proliferative effect of guggulipidNeurological Sciences, 2013
- Anti-Inflammatory Activity of Different Agave Plants and the Compound Cantalasaponin-1Molecules, 2013
- Effects of ginsenoside Re on LPS-induced inflammatory mediators in BV2 microglial cellsBMC Complementary and Alternative Medicine, 2012
- Steroidal saponins from the whole plants of Agave utahensis and their cytotoxic activityPhytochemistry, 2009
- Antifungal Activity of C-27 Steroidal SaponinsAntimicrobial Agents and Chemotherapy, 2006
- Constituents of Agave americana and Agave barbadensisFitoterapia, 2005
- Molecular Structures of Fructans from Agave tequilana Weber var. azulJournal of Agricultural and Food Chemistry, 2003
- Anti-Inflammatory Activity of Aqueous Extracts and Steroidal Sapogenins ofAgave americanaPlanta Medica, 1997
- Antitumor Agents from Agave schottii(Amaryllidaceae)Journal of Pharmaceutical Sciences, 1969
- Sterols. CLVII. Sapogenins. LXIX.1 Isolation and Structures of Thirteen New Steroidal Sapogenins. New Sources for Known SapogeninsJournal of the American Chemical Society, 1943